Lilly holds industry-leading growth potential as the company is launching several new blockbusters and patent losses are fading. We’re maintaining our $580 fair value estimate for Eli Lilly and ...

We recently published a list of the 10 High Growth Forever Dividend Stocks to Invest In. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other ...

The tortoise (Eli Lilly) has caught the hare (Novo Nordisk), according to a report from BMO Capital Markets, which cites the superior commercial and clinical portfolios of the Indianapolis company ...